OK, accept all
Technology & Products
NOVADIP BIOSCIENCES appoints Jeff Abbey as CEO
Mont-Saint-Guibert, Belgium – December 12, 2018 – NOVADIP BIOSCIENCES, a regenerative medicine company and pioneer in the growth of 3-dimensional tissues derived from adipose stem cells for hard ...
NOVADIP appoints Eric Paul Pâques as Chairman of the Board
Mont-Saint-Guibert, Belgium – May 30, 2017 – Advanced biopharmaceutical company NOVADIP BIOSCIENCES, which pioneers the growth of 3-dimensional tissues derived from adipose stem cells to ...
Fast-growing biopharmaceutical company NOVADIP develops its product portfolio and moves to new premises offering on-site R&D and GMP facilities
Mont-Saint-Guibert, Belgium - June 21, 2016 - NOVADIP BIOSCIENCES, a biopharmaceutical spin-off company of Université catholique de Louvain, announces the official opening of its new site in ...
Novadip closes EUR 28 million Series A Round with US and Belgian investors to advance breakthrough cell therapy pipeline
EN - FR - NL Louvain-la-Neuve, Belgium - September 10, 2015 – Novadip Biosciences, a biopharmaceutical spin-off company of Université catholique de Louvain announces the successful closing of a ...
Gil beyen joins novadip biosciences board of directors
Louvain-la-Neuve, Belgium - December 15, 2014 – NOVADIP BIOSCIENCES, an innovative biopharmaceutical company specializing in the discovery and development of new generation of regenerative and ...